Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Huntington's Disease | Letter to the Editor

Satellite cell content in Huntington’s disease patients in response to endurance training

Authors: Sandro Manuel Mueller, Violeta Mihaylova, Sebastian Frese, Jens A. Petersen, Maria Ligon-Auer, David Aguayo, Martin Flück, Hans H. Jung, Marco Toigo

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

Skeletal muscle wasting is a hallmark of Huntington’s disease (HD). However, data on myocellular characteristics and myofiber remodeling in HD patients are scarce. We aimed at gaining insights into myocellular characteristics of HD patients as compared to healthy controls at rest and after a period of increased skeletal muscle turnover.

Methods

Myosin heavy chain (MyHC)-specific cross-sectional area, satellite cell content, myonuclear number, myonuclear domain, and muscle fiber type distribution were determined from vastus lateralis muscle biopsies at rest and after 26 weeks of endurance training in HD patients and healthy controls.

Results

At the beginning of the study, there were no differences in myocellular characteristics between HD patients and healthy controls. Satellite cell content per MyHC-1 fiber (P = 0.014) and per MyHC-1 myonucleus (P = 0.006) increased significantly in healthy controls during the endurance training intervention, whereas it remained constant in HD patients (P = 0.804 and P = 0.975 for satellite cell content per MyHC-1 fiber and myonucleus, respectively). All further variables were not altered during the training intervention in HD patients and healthy controls.

Conclusions

Similar skeletal muscle characteristics between HD patients and healthy controls at baseline suggested similar potential for myofiber remodeling in response to exercise. However, the missing satellite cell response in MyHC-1 myofibers following endurance training in HD patients points to a potential dysregulation in the exercise-induced activation and/or proliferation of satellite cells. In the longer-term, impaired myonuclear turnover might be associated with the clinical observation of skeletal muscle wasting.
Literature
1.
go back to reference Arenas J, Campos Y, Ribacoba R, et al. Complex I defect in muscle from patients with Huntington’s disease. Ann Neurol. 1998;43:397–400.CrossRef Arenas J, Campos Y, Ribacoba R, et al. Complex I defect in muscle from patients with Huntington’s disease. Ann Neurol. 1998;43:397–400.CrossRef
2.
go back to reference Gehrig SM, Petersen JA, Frese S, et al. Skeletal muscle characteristics and mitochondrial function in Huntington's disease patients. Mov Disord. 2017;32:1258–9.CrossRef Gehrig SM, Petersen JA, Frese S, et al. Skeletal muscle characteristics and mitochondrial function in Huntington's disease patients. Mov Disord. 2017;32:1258–9.CrossRef
3.
go back to reference Lodi R, Schapira AH, Manners D, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol. 2000;48:72–6.CrossRef Lodi R, Schapira AH, Manners D, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol. 2000;48:72–6.CrossRef
4.
go back to reference Saft C, Zange J, Andrich J, et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord. 2005;20:674–9.CrossRef Saft C, Zange J, Andrich J, et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord. 2005;20:674–9.CrossRef
5.
go back to reference Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M. Skeletal muscle pathology in Huntington’s disease. Front Physiol. 2014;5:380.CrossRef Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M. Skeletal muscle pathology in Huntington’s disease. Front Physiol. 2014;5:380.CrossRef
6.
go back to reference Mielcarek M, Smolenski RT, Isalan M. Transcriptional signature of an altered purine metabolism in the skeletal muscle of a Huntington’s disease mouse model. Front Physiol. 2017;8:127.CrossRef Mielcarek M, Smolenski RT, Isalan M. Transcriptional signature of an altered purine metabolism in the skeletal muscle of a Huntington’s disease mouse model. Front Physiol. 2017;8:127.CrossRef
7.
go back to reference Mielcarek M, Isalan M. A shared mechanism of muscle wasting in cancer and Huntington’s disease. Clin Transl Med. 2015;4:34.CrossRef Mielcarek M, Isalan M. A shared mechanism of muscle wasting in cancer and Huntington’s disease. Clin Transl Med. 2015;4:34.CrossRef
8.
go back to reference Cubo E, Rivadeneyra J, Gil-Polo C, Armesto D, Mateos A, Mariscal-Pérez N. Body composition analysis as an indirect marker of skeletal muscle mass in Huntington’s disease. J Neurol Sci. 2015;358:335–8.CrossRef Cubo E, Rivadeneyra J, Gil-Polo C, Armesto D, Mateos A, Mariscal-Pérez N. Body composition analysis as an indirect marker of skeletal muscle mass in Huntington’s disease. J Neurol Sci. 2015;358:335–8.CrossRef
9.
go back to reference Frese S, Petersen JA, Ligon-Auer M, et al. Exercise effects in Huntington disease. J Neurol. 2017;264:32–9.CrossRef Frese S, Petersen JA, Ligon-Auer M, et al. Exercise effects in Huntington disease. J Neurol. 2017;264:32–9.CrossRef
10.
go back to reference Pratley RE, Salbe AD, Ravussin E, Caviness JN. Higher sedentary energy expenditure in patients with Huntington’s disease. Ann Neurol. 2000;47:64–70.CrossRef Pratley RE, Salbe AD, Ravussin E, Caviness JN. Higher sedentary energy expenditure in patients with Huntington’s disease. Ann Neurol. 2000;47:64–70.CrossRef
11.
go back to reference Süssmuth SD, Müller VM, Geitner C, et al. Fat-free mass and its predictors in Huntington’s disease. J Neurol. 2015;262:1533–40.CrossRef Süssmuth SD, Müller VM, Geitner C, et al. Fat-free mass and its predictors in Huntington’s disease. J Neurol. 2015;262:1533–40.CrossRef
12.
go back to reference Mueller SM, Gehrig SM, Petersen JA, et al. Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients. Orph J Rare Dis. 2017;12:184.CrossRef Mueller SM, Gehrig SM, Petersen JA, et al. Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients. Orph J Rare Dis. 2017;12:184.CrossRef
Metadata
Title
Satellite cell content in Huntington’s disease patients in response to endurance training
Authors
Sandro Manuel Mueller
Violeta Mihaylova
Sebastian Frese
Jens A. Petersen
Maria Ligon-Auer
David Aguayo
Martin Flück
Hans H. Jung
Marco Toigo
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1115-4

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue